Yan Sun

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Hepatology, Medicine, Cancer Management +12

Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia

Shukui Qin, Yuxian Bai, Ho Yeong Lim et al. · Journal of Clinical Oncology · 2013 · 501 citations · Full text

Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial

Yi‐Long Wu, Jin Soo Lee, Sumitra Thongprasert et al. · The Lancet Oncology · 2013 · 304 citations

Oncology, Medicine, Metronomic Therapy +6

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Bonne Biesma, David F. Heigener et al. · Journal of Clinical Oncology · 2012 · 256 citations · Full text

PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody

Gao‐Chao Lv, Xiaorong Sun, Ling Qiu et al. · Journal of Nuclear Medicine · 2019 · 175 citations · Full text